A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer
Clinical trial NCT05871918 · UNKNOWN
Trial details
- NCT number
- NCT05871918
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-08
- Primary completion
- 2023-12-31
- Enrollment
- 832
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.